Fragile X mouse: Strain effects of knockout phenotype and evidence suggesting deficient amygdala function

Neuroscience

Volumn 94, Issue 1, 1999, Pages 185-192

  Paradee, W ^a   Melikian, H E ^a   Rasmussen, D L ^a   Kenneson, A ^a   Conn, P J ^a   Warren, S T ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Conditional fear; Fragile X syndrome; Genetics; Long term potentiation; Mouse; Spatial learning

Indexed keywords

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; FRAGILE X SYNDROME; GENETICS; INSTRUMENTAL CONDITIONING; KNOCKOUT MOUSE; LONG TERM POTENTIATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DENSITY; SPATIAL DISCRIMINATION; STRAIN DIFFERENCE;

AMYGDALA; ANIMALS; CONDITIONING (PSYCHOLOGY); ELECTROPHYSIOLOGY; FEAR; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; GENOTYPE; HIPPOCAMPUS; LONG-TERM POTENTIATION; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; PHENOTYPE; RNA-BINDING PROTEINS; SPATIAL BEHAVIOR;

EID: 0032881856     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00285-7     Document Type: Article

References (54)

1. Abraham W.C., Mason S.E., Demmer J., Williams J.M., Richardson C.L., Tate W.P., Lawlor P.A., Dragunow M. Correlations between immediate early gene induction and the persistence of long-term potentiation. Neuroscience. 56:1993;717-727.
2. Ashley C.T., Wilkinson K.D., Reines D., Warren S.T. FMR1 protein: conserved RNP family domains and selective RNA binding. Science. 262:1993;563-566.
3. Bakker C.E., The Dutch-Belgian Fragile X Consortium. Fmr1 knockout mice: a model to study fragile X mental retardation. Cell. 78:1994;23-33.
4. Cianchetti C., Sannio Fancello G., Fratta A.L., Manconi R., Orano A., Pischedda M.P., Pruna D., Spinicci G., Archidiacono N., Filippi G. Neuropsychological, psychiatric, and physical manifestations in 149 members from 18 fragile X families. Am. J. Med. Genet. 40:1991;234-243.
5. Comery T.A., Harris J.B., Willems P.J., Oostra B.A., Irwin S.A., Weiler I.J., Greenough W.T. Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc. natn. Acad. Sci. U.S.A. 94:1997;5401-5404.
6. Crawley J.N., Belknap J.K., Collins A., Crabbe J.C., Frankel W., Henderson N., Hitzemann R.J., Maxson S.C., Miner L.L., Silva A.J., Wehner J.M., Wynshaw-Boris A., Paylor R. Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology. 132:1997;107-124.
7. D'Hooge R., Nagels G., Franck F., Bakker C., Reyniers E., Storm K., Kooy R., Oostra B., Willems P., DeDeyn P. Mildly impaired water maze performance in male Fmr1 knockout mice. Neuroscience. 76:1997;367-376.
8. Eberhart D.E., Malter H.E., Feng Y., Warren S.T. The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals. Hum. molec. Genet. 5:1996;1083-1091.
9. Engler P., Haasch D., Pinkert C.A., Doglio L., Glymour M., Brinster R., Storb U. A strain-specific modifier on mouse chromosome 4 controls the methylation of independent transgene loci. Cell. 65:1991;939-947.
10. Feng Y., Gutekunst C.-A., Eberhart D.E., Yi H., Warren S.T., Hersch S.M. Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes. J. Neurosci. 17:1997;1539-1547.
11. Feng Y., Absher D., Eberhart D.E., Brown V., Malter H.E., Warrren S.T. FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association. Molec. Cell. 1:1997;109-118.
12. Frey U., Krug M., Reymann K.G., Matthies H. Anisomycin, an inhibitor of protein synthesis, blocks late phases of LTP phenomena in the hippocampal CA1 region in vitro. Brain Res. 452:1988;57-65.
13. Frey U., Frey S., Schollmeier F., Krug M. Influence of actinomycin D, an RNA synthesis inhibitor, on long-term potentiation in rat hippocampal neurons in vivo and in vitro. J. Physiol. 490:1996;703-711.
14. Frey U., Morris R.G.M. Synaptic tagging and long-term potentiation. Science. 385:1997;533-536.
15. Godfraind J.M., Reyniers E., DeBoulle K., D'Hooge R., De Deyn P.P., Bakker C.E., Oostra B.A., Kooy R.F., Willems P.J. Long-term potentiation in the hippocampus of fragile X knockout mice. Am. J. Med. Genet. 64:1996;246-251.
16. Hagerman R. (1998) Clinical and diagnostic aspects of fragile X syndrome. In Genetic Instabilities and Hereditary Neurological Diseases (eds Wells R. D. and Warren S. T.), pp. 15-25. Academic, San Diego.
17. Hergersberg M., Matsuo K., Gassmann M., Schaffner W., Lüscher B., Rülicke T., Aguzzi A. Tissue-specific expression of a FMR1/b-galactosidase fusion gene in transgenic mice. Hum. molec. Genet. 4:1995;359-366.
18. Hinds H.L., Ashley C.T., Nelson D.L., Warren S.T., Housman D.E., Shalling M. Tissue specific expression of FMR1 provides evidence for a functional role in fragile X syndrome. Nature Genet. 3:1993;36-43.
19. Imbert G., Feng Y., Nelson D. L., Warren S. T. and Mandel J.-L. (1998) FMR1 and mutations in fragile X syndrome: molecular biology, biochemistry and genetics. In Genetic Instabilities and Hereditary Neurological Diseases (eds Wells R. D. and Warren S. T.), pp. 27-53. Academic, San Diego.
20. Kelly M.A., Rubinstein M., Phillips T.J., Lessov C.N., Burkhart-Kasch S., Zhang G., Bunzow J.R., Fang Y., Gerhardt G.A., Grandy D.K., Low M.J. Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations. J. Neurosci. 18:1998;3470-3479.
21. Khandjian E.W., Fortin A., Thibodeau A., Tremblay S., Côté F., Devys D., Mandel J.-L., Rousseau R. A heterogeneous set of FMR1 proteins is widely distributed in mouse tissues and is modulated in cell culture. Hum. molec. Genet. 4:1995;783-789.
22. Khandjian E.W., Corbin F., Woerly S., Rousseau F. The fragile X mental retardation protein is associated with ribosomes. Nature Genet. 12:1996;91-93.
23. Kim J.J., Rison R.A., Fanselow M.S. Effects of amygdala, hippocampus and periaqueductal gray lesions on short- and long-term contextual fear. Behav. Neurosci. 107:1993;1093-1098.
24. Kjerrulf M., Grdic D., Kopf M., Lycke N. Induction of gut mucosal immune responses: importance of genetic background and Th1/Th2 cross-regulation. Scand. J. Immun. 47:1998;401-407.
25. Kojima N., Wang J., Mansuy I.M., Grant S.G., Mayford M., Kandel E.R. Rescuing impairment of long-term potentiation in fyn-deficient mice by introducing fyn transgene. Proc. natn. Acad. Sci. U.S.A. 94:1997;4761-4765.
26. Kooy R., D'Hooge R., Reyniers E., Bakker C., Nagels G., DeBoulle K., Storm K., Clinke G., DeDeyn P., Oostra B., Willems P. Transgenic mouse model for the fragile X syndrome. Am. J. Med. Genet. 64:1996;241-245.
27. Larson J., Lynch G. Induction of synaptic potentiation in hippocampus by patterned stimulation involves two events. Science. 232:1986;985-988.
28. LeCouter J., Kablar B., Hardy W.R., Ying C., Megeney L.A., May L.L., Rudnicki M.A. Strain-dependent myeloid hyperplasia, growth deficiency, and accelerated cell cycle in mice lacking the Rb-related p107 gene. Molec. cell. Biol. 18:1998;7455-7465.
29. LeDoux J. Emotion: clues from the brain. A. Rev. Psychol. 46:1995;209-235.
30. Maes B., Fryns J.P., Vanwalleghem M., Vandenberghe H. Cognitive functioning and information processing of adult mentally retarded men with fragile X syndrome. Am. J. Med. Genet. 50:1994;190-200.
31. Mayford M., Wang J., Kandel E.R., O'Dell T.J. CaMKII regulates the frequency-response function of hippocampal synapses for the production of both LTD and LTP. Cell. 81:1995;891-904.
32. McNamara R.K., Stumpo D.J., Morel L.M., Lewis M.H., Wakeland E.K., Blackshear P.J., Lenox R.H. Effect of reduced myristolated alanine-rich C kinase substrate expression on hippocampal mossy fiber development and spatial learning in mutant mice: transgenic rescue and interactions with gene background. Proc. natn. Acad. Sci. U.S.A. 95:1998;14,517-14,522.
33. Morris R.G.M. Spatial localization does not require the presence of local cues. Learn. Motiv. 12:1981;239-260.
34. Morton J.E., Bundey S., Webb T.P., MacDonald F., Rindl P.M., Bullock S. Fragile X syndrome is less common than previously estimated. J. Med. Genet. 34:1997;1-5.
35. Nguyen P.V., Abel T., Kandel E.R. Requirement of a critical period of transcription for induction of a late phase of LTP. Science. 265:1994;1104-1107.
36. Oberlé I., Rosseau F., Heitz D., Kretz C., Devys D., Hanover A., Boue J., Bertheas M., Mandel J. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science. 252:1991;1097-1102.
37. Oostra B. A. and Willems P. J. (1998) Murine model of fragile X syndrome. In Genetic Instabilities and Hereditary Neurological Diseases (eds Wells R. D. and Warren S. T.), pp. 55-62. Academic, San Diego.
38. Otani S., Abraham W.C. Inhibition of protein synthesis in the dentate gyrus, but not the entorhinal cortex, blocks maintenance of long-term potentiation in rats. Neurosci. Lett. 106:1989;175-180.
39. Owen E.H., Logue S.F., Rasmussen D.L., Wehner J.M. Assessment of learning by the Morris water task and fear conditioning in inbred mouse strains and F1 hybrids: implications of genetic background for single gene mutations and quantitative trait loci analysis. Neuroscience. 80:1997;1087-1099.
40. Paylor R., Tracy R., Wehner J., Rudy J.W. DBA/2 and C57BL/6 mice differ in contextual fear but not auditory fear conditioning. Behav. Neurosci. 108:1994;810-817.
41. Phillips R.G., LeDoux J.E. Differential contribution of the amygdala and hippocampus to cued and contextual fear conditioning. Behav. Neurosci. 106:1992;274-285.
42. Pieretti M., Zhang F., Fu Y.-H., Warren S.T., Oostra B.A., Caskey C.T., Nelson D.L. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell. 66:1991;817-822.
43. Reiss A., Freund L. Behavioral phenotype of fragile X syndrome: DSM-III-R autistic behavior in male children. Am. J. Med. Genet. 43:1992;35-46.
44. Silva A.J., Stevens C.F., Tonegawa S., Wang Y. Deficient hippocampal long-term potentiation in calcium-calmodulin kinase II mutant mice. Science. 257:1992;201-206.
45. Simpson E.M., Linder C.C., Sargent E.E., Davisson M.T., Mobraaten L.E., Sharp J.J. Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice. Nature Genet. 16:1997;19-27.
46. Stäubli U., Lynch G. Stable hippocampal long-term potentiation elicited by "theta" pattern stimulation. Brain Res. 435:1987;227-234.
47. Sutcliffe J.S., Nelson D.L., Zhang F., Pieretti M., Caskey C.T., Saxe D., Warren S.T. DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum. molec. Genet. 1:1992;397-400.
48. Tamanini F., Meijer N., Verheij C., Willems P.J., Galjaard H., Oostra B.A., Hoogeveen A.T. FMRP is associated to the ribosomes via RNA. Hum. molec. Genet. 5:1996;809-813.
49. Threadgill D.W., Yee D., Matin A., Nadeau J.H., Magnuson T. Genealogy of the 129 strains: 129/SvJ is a contaminated inbred strain. Mamm. Genome. 8:1997;390-393.
50. Turner G., Webb T., Wake S., Robinson H. Prevalence of fragile X syndrome. Am. J. Med. Genet. 64:1996;196-197.
51. Verheij C., Bakker C.E., de Graaff E., Keulemans J., Willemsen R., Verkerk A.J.M.H., Galjaard H., Reuser A.J.J., Hoogeveen A.T., Oostra B.A. Characterization and localization of the FMR-1 gene product associated with fragile X syndrome. Nature. 363:1993;722-724.
52. Verkerk A.J.M.H., Pieretti M., Sutcliffe J.S., Fu Y.-H., Kuhl D.P.A., Pizzuti A., Reiner O., Richards S., Victoria M.F., Zhang F., Eussen B.E., van Ommen G.-J. B., Blonden L.A.J., Riggins G.J., Chastain J.L., Kunst C.B., Galjaard H., Caskey C.T., Nelson D.L., Oostra B.A., Warren S.T. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell. 65:1991;905-914.
53. Willemson R., Bontekoe C., Tamanini F., Galjaard H., Hoogeveen A., Oostra B. Association of FMRP with ribosomal precursor particles in the nucleolus. Biochem. biophys. Res. Commun. 225:1996;27-33.
54. Zucker R.S. Short-term synaptic plasticity. A. Rev. Neurosci. 12:1989;13-31.